Sudhir R. Brahmbhatt, Ph.D., MBA is President of Technology Services Inc. based in St. Louis, MO. He has wealth of knowledge in the Environmental, Chemical, Pharma, Biotechnology, and Metal industries and has invented more than 30 patents in these areas with 5+ patents in the pharma and biotech area. We caught up with Dr. Brahmbhatt to learn more about his company, recent changes he’s seen in the industry due to the pandemic, and what he’s looking forward to at INTERPHEX this year.
Road to NYC: March 2021
Exhibitor Spotlight: Darren Hieber, Vice President, Business Development, Drug Product, Catalent Biologics
Darren Hieber was named Vice President of Catalent Biologics’ North American business development team in September 2020, leading their drug product sales efforts, and was previously Sr. Account Director for several of Catalent’s largest strategic drug product customers. We caught up with Darren to learn more about what makes Catalent Biologics unique, insights into new technology, and top trends he sees leading the industry.
An Industry Leader’s Look to the Future
How many times have we all heard over the past 12 months that this has been a year like no other? While the pharmaceutical manufacturing industry was already accelerating at record pace, the COVID-19 pandemic became the catalyst for even more rapid change and innovation. Many of the lessons learned over the last year will be applied not only to the coronavirus and other vaccines, but also, will have a lasting impact on the direction of our industry for years to come.